SoftOx is developing a range of products that can be classified as either medical devices or medicinal products (drugs) for human use. Collectively, our R&D efforts are focused on prevention and eradication of serious infections. Such infections are not limited to pathogenic bacteria, but may also include viral and fungal infections. Our current product candidates are either in the clinical or late stage preclincal (animal testing) phase.
- SoftOx Wound Irrigation Solutions (medical device) for acute and chronic wounds, to both prevent and treat infections (including biofilms).
- SoftOx Anti-infectives are products aimed to actively treat and remove topical infections in wounded and mucosal tissues, such as those caused by biofilms, AMR microbes, viruses and fungi.